In an amicus brief filed in Ortho Biotech Products v. United States ex rel. Mark Eugene Duxbury, the AHA said that if the First Circuit Court of Appeals’ decision were not reversed, it would undermine two key requirements for FCA actions:
- That private individuals attempting to bring lawsuits not trade on fraud allegations already disclosed to the public; and
- That they have specific knowledge of false or fraudulent claims before filing the case.
Read AHA News Now’s report on the False Claims Act.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
